| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net revenues | 83,043 | 86,188 | 87,988 | 85,782 |
| Cost of sales (exclusive of amortization of acquired intangible assets) | 18,704 | 17,626 | 16,383 | 15,609 |
| Research and development | 12,960 | 12,787 | 12,588 | 12,323 |
| Selling, general and administrative | 55,907 | 58,065 | 58,620 | 50,499 |
| Amortization of acquired intangible assets | 2,276 | 1,961 | 28,325 | 2,272 |
| Total operating expenses, net | 89,847 | 90,439 | 115,916 | 80,703 |
| Operating (loss) income | -6,804 | -4,251 | -27,928 | 5,079 |
| Interest income | 2,833 | 2,944 | 3,099 | 3,404 |
| Changes in fair value of equity securities | 3,561 | 1,185 | -1,425 | - |
| Interest expense | 24 | 21 | 17 | 201 |
| Other expense | 48 | - | - | - |
| (loss) income before income taxes | -386 | -143 | -26,271 | 8,282 |
| Income tax expense (benefit) | 115 | -4,666 | -423 | 6,013 |
| Net (loss) income | -501 | 4,523 | -25,848 | 2,269 |
| Basic (in dollars per share) | -0.02 | 0.16 | -0.9 | 0.08 |
| Basic (in shares) | 29,073,000 | 28,914,000 | 28,609,000 | 27,840,000 |
| Diluted (in dollars per share) | -0.02 | 0.15 | -0.9 | 0.08 |
| Diluted (in shares) | 29,073,000 | 29,545,000 | 28,609,000 | 29,401,000 |
CASTLE BIOSCIENCES INC (CSTL)
CASTLE BIOSCIENCES INC (CSTL)